REVO News 0.0087 05/09/2014 05:23:37 Revolutionary Conc (REV

New Post Public Reply Private Reply Replies (0) Message Board

May 9, 2014 at 6:23 AM

Revolutionary Conc (REVO) 0.0087 $REVO

Revolutionary Concepts Inc. Advances Negotiations With Developer in Three Billion Dollar Toy Market With Focus on Smart Toy and Cloud Based Interaction
Marketwire - Wed Mar 26, 1:15PM CDT
Revolutionary Concepts Inc. (OTCQB: REVO), a publicly traded company that develops mobile video software and remote security communication systems, has begun advanced contract negotiations to further the process of bringing its Smart Toy technology to market via patent sale and/or licensing agreements.

Revolutionary Concepts Inc. Forecasts up to $30 Million in Annual Revenue
ACCESSWIRE - Fri Mar 21, 8:40AM CDT
Revolutionary Concepts Inc. (OTCQB: REVO), a security technology and monitoring company in the developmental stage, saw its volume soar Mar. 20, with 14,797,383 shares changing hands.

Revolutionary Concepts Forecasts $30 Million in Revenues, Announces Major Plans to Increase Investor Returns and Shareholder Value
Marketwire - Wed Mar 19, 11:25AM CDT
Revolutionary Concepts Inc., (OTCQB: REVO), a publicly traded company that develops mobile video software and remote security communication systems, plans major new initiatives to significantly increase investor returns and improve shareholder value. After REVO announced it signed a multi-year global licensing agreement with its Licensee to commercialize REVO's patented "EyeTalk Communicator System", REVO is forecasting $20 to $30 million in total estimated annual revenues from residual licensing fees and royalties.

Revolutionary Concepts Stock Rises 873%, Breaks Trading Barriers, Trades 79.26 Million Shares
Marketwire - Wed Feb 19, 2:00PM CST
Revolutionary Concepts Inc., (OTCQB: REVO), a publicly traded company that develops online mobile video software and remote security communication systems, announced that shares of its common stock rose in price more than 842%, in the past two weeks. Based on today's intraday trading, its price has traded as high as $0.0185, as compared to its previous low closing price set on Monday, February 3, 2014. On Tuesday, February 18, 2014, the Company's stock traded over 70.26 million shares

Revolutionary Concepts Announces Major Plans to Maximize Revenues From Its Global License Agreement of Its Online Smart Technology Security System
Marketwire - Tue Feb 18, 10:40AM CST
Revolutionary Concepts Inc. (OTCQB: REVO), a publicly traded company that develops online mobile video software and remote security communication systems, announced it is working in conjunction with the Licensee that it signed a global multi-year licensing agreement to aggressively commercialize REVO's patented "EyeTalk Communicator System." Both companies are reviewing various options and alternatives to fully exploit and maximize the potential financial revenues and profits that could be obtained from the patents and license agreement.

Revolutionary Concepts Stock Soars 182%, on News of Global License Deal, Forecasts $30 Million in Sales, and Sets New Trading Record of 120 Million Shares Sold
Marketwire - Thu Feb 13, 9:55AM CST
Revolutionary Concepts Inc., (OTCQB: REVO), a publicly traded company that develops online mobile video software and remote security communication systems, announced that shares of its common stock broke all previous trading records and soared more than 182%. A record 120,588,619 shares of its stock traded on Wednesday, February 12, 2014, after REVO reported that it signed a multi-year global licensing agreement with a company for them to commercialize REVO's patented "EyeTalk Communicator System."

Revolutionary Concepts, Inc. Nears Final Stages in Sell of Security Patents and Children's Toy Licensing
GlobeNewswire - Tue Nov 12, 1:57PM CST
Revolutionary Concepts, Inc., a company focused on the design and development of intellectual property (IP) rights, and trade names such as Eye Talk Communicator (OTCBB:REVO) (www.revolutionaryconceptsinc.com) confirmed today that negotiations involving a recent Letter Of Intent are still underway and progressing positively.

Revolutionary Concepts, Inc. Reveals Additional Information on Potential Sale of Patent Portfolio
ACCESSWIRE - Wed Sep 18, 1:25PM CDT
CHARLOTTE, NC September 18, 2013 - (ACCESSWIRE) - Revolutionary Concepts, Inc., a company focused on the design and development of intellectual property (IP) rights, and trade names such as Eye Talk Communicator (OTCQB: REVO) (http://www.revolutionaryconceptsinc.com/) could receive an immediate benefit of several hundred thousand dollars from the sale and/or license of patents, discussed in our previous press release.

Revolutionary Concepts, Inc. Seeks Board Approval to Close Sale of Multi-Million Dollar Patent Portfolio
Marketwire - Thu Sep 12, 1:13PM CDT
Revolutionary Concepts, Inc., a company focused on the design and development of intellectual property (IP) rights, and trade names such as Eye Talk Communicator (OTCQB: REVO) (www.revolutionaryconceptsinc.com) seeks Director approval for shareholder vote to finalize the sale and/or license of patents.

Revolutionary Concepts, Inc. Estimates Revenues Generate From Licensing Fees
GlobeNewswire - Fri Sep 06, 9:00AM CDT
Revolutionary Concepts, Inc. (OTCBB:REVO) (www.revolutionaryconceptsinc.com), a company focused on the design and development of intellectual property (IP) rights, and trade names such as Eye Talk Communicator discussed the marketability of the patent portfolio and estimations of licensing fees.

Revolutionary Concepts, Inc. Signs Letter of Intent for Patent Rights
GlobeNewswire - Tue Sep 03, 2:15PM CDT
Revolutionary Concepts, Inc. is a company focused on the design and development of intellectual property (IP) rights, and trade names such as Eye Talk Communicator. Revolutionary Concepts, Inc. (OTCBB:REVO) (www.revolutionaryconceptsinc.com) announced today that it has executed a Letter of Intent with an undisclosed third party to acquire the rights to patents US 7,193,644 B2; US 8,139,089 B2; US 8,144,183 B2; US 8,144,184 B2; US 8,154,581 B2; US 8,164,614 B2 as well as negotiate licensing agreements.

Revolutionary Concepts, Inc. Expects First Revenue Beginning in 3rd Quarter 2013
GlobeNewswire - Tue Sep 03, 8:49AM CDT
Revolutionary Concepts, Inc., a company focused on the design and development of intellectual property (IP) rights, and trade names such as Eye Talk Communicator, (OTCBB:REVO) (www.revolutionaryconceptsinc.com) announced today that financial improvement is expected in the quarter ended September 30, 2013 inclusive of the following highlights:

Revolutionary Concepts, Inc. Projects Millions in Profits Through Its Subsidiary Greenwood Finance Group, LLC
GlobeNewswire - Tue Aug 27, 6:47AM CDT
"EyeTalk Communicator" developer Revolutionary Concepts, Inc. (OTCBB:REVO) (www.revolutionaryconceptsinc.com) announces its subsidiary Greenwood Finance Group, LLC has completed the set-up of a new infrastructure in addition to completing several investment transactions.

Revolutionary Concepts, Inc. Joint Venture Completes Toy Product Development
GlobeNewswire - Thu Jan 31, 9:40AM CST
"EyeTalk Communicator" developer Revolutionary Concepts, Inc. (OTCBB:REVO) (www.revolutionaryconceptsinc.com), is pleased to announce that IQmagine has completed the initial product development of the toy project. Additional features of the toy project will not be disclosed at this time, however the company is excited that the product development is completed and proved very successful. The product development was conducted by Enventys, a unique innovative company located in Charlotte, NC dedicated to new innovative product development, sales, branding and licensing.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...